F2RL1 and colorectal carcinoma: The higher gene expression of F2RL1 (PAR‐2) in colorectal carcinoma chemotherapy non‐responders compared to responders in the publically available ROC Plotter resource may be an indication of pro‐proliferative signalling via TF/FXa/FVIIa.34, 35